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Aim To describe and discuss the merits of various direct 
and indirect methods applied in vitro (mainly on blood or 
milk) or in vivo (allergic test) for the diagnosis of brucellosis 
in animals.
Methods The recent literature on brucellosis diagnostic 
tests was reviewed. These diagnostic tests are applied with 
different goals, such as national screening, confirmatory 
diagnosis, certification, and international trade. The valida-
tion of such diagnostic tests is still an issue, particularly in 
wildlife. The choice of the testing strategy depends on the 
prevailing brucellosis epidemiological situation and the 
goal of testing.
Results Measuring the kinetics of antibody production 
after Brucella spp. infection is essential for analyzing sero-
logical results correctly and may help to predict abortion. 
Indirect ELISAs help to discriminate 1) between false posi-
tive serological reactions and true brucellosis and 2) be-
tween vaccination and infection. Biotyping of Brucella spp. 
provides valuable epidemiological information that allows 
tracing an infection back to the sources in instances where 
several biotypes of a given Brucella species are circulating. 
Polymerase chain reaction and new molecular methods 
are likely to be used as routine typing and fingerprinting 
methods in the coming years.
Conclusion The diagnosis of brucellosis in livestock and 
wildlife is complex and serological results need to be care-
fully analyzed. The B. abortus S19 and B. melitensis Rev. 1 
vaccines are the cornerstones of control programs in cattle 
and small ruminants, respectively. There is no vaccine avail-
able for pigs or for wildlife. In the absence of a human bru-
cellosis vaccine, prevention of human brucellosis depends 
on the control of the disease in animals.
Jacques Godfroid1, 
Klaus Nielsen2, Claude 
Saegerman3
1Section of Arctic Veterinary 
Medicine, Department of Food 
Safety and Infection Biology, 
Norwegian School of Veterinary 
Science, Tromsø, Norway
2Canadian Food Inspection Agency, 
Ottawa Fallowfield Laboratory, 
Brucellosis Centre of Expertise, 
OIE Reference Laboratory for the 
Americas, ISO 17025 Accredited, 
Ottawa, Ontario, Canada
3Epidemiology and Risk Analysis 
Applied to Veterinary Sciences, 
Department of Infectious and 
Parasitic Diseases, Faculty of 
Veterinary Medicine, University of 
Liege, Ličge, Belgium
Received: February 9, 2010
Accepted: June 18, 2010
Correspondence to: 
Jacques Godfroid 
Head of the Section of Arctic 
Veterinary Medicine 
Department of Food Safety and 
Infection Biology 
Norwegian School of Veterinary 
Science 
Stakkevollveien 23 
9010 Tromsø, Norway 
jacques.godfroid@nvh.no





297Godfroid et al: Diagnosis of Brucellosis in Animals
www.cmj.hr
Brucellae are Gram-negative, facultative intracellular bacte-
ria that can infect many species of animals and man. Ten 
species are recognized within the genus Brucella. There 
are 6 “classical” species: Brucella abortus, Brucella melitensis, 
Brucella suis, Brucella ovis, Brucella canis, and Brucella neoto-
mae (1,2). This classification is based mainly on differences 
in pathogenicity and host preference (3). Distinction be-
tween species and between biovars of a given species is 
currently performed using differential tests based on phe-
notypic characterization of lipopolysaccharide (LPS) anti-
gens, phage typing, dye sensitivity, requirement for CO2, 
H2S production, and metabolic properties (1,2).
The main pathogenic species worldwide are B. abortus, re-
sponsible for bovine brucellosis; B. melitensis, the main eti-
ologic agent of ovine and caprine brucellosis; and B. suis, 
responsible for swine brucellosis. These 3 Brucella species 
cause abortion (“abortion storm” in naive heifers), and when 
brucellosis is detected in a herd, flock, region, or country, 
international veterinary regulations impose restrictions on 
animal movements and trade, which result in huge eco-
nomic losses. These are the reasons why programs to con-
trol or eradicate brucellosis in cattle, small ruminants, and 
pigs have been implemented worldwide (4).
B. ovis and B. canis are responsible for ram epididymitis 
and canine brucellosis, respectively. In the case of B. neoto-
mae, only strains isolated from desert wood rat (Neotoma 
lepida) in North America have been reported. Recently 4 
new Brucella species have been described: Brucella pinni-
pedialis and Brucella ceti, isolated predominantly from seals 
and cetaceans, respectively (5); Brucella microti, isolated 
from common voles (Microtus arvalis) (6), soil (7), and foxes 
(Vulpes vulpes) (8); and Brucella inopinata, isolated from a 
breast implant (9).
There is a general host restriction pattern among the dif-
ferent Brucella species, meaning that different Brucella spe-
cies infect different preferred hosts. Even within the B. suis 
species, different biovars preferentially infect different ani-
mal host species (1-3). Indeed, B. suis biovars 1 and 3 infect 
suidae, biovar 2 infects suidae and hare (Lepus europeanus), 
biovar 4 infects reindeer (Rangifer tarandus tarandus) and 
caribou (Rangifer tarandus granti), and biovar 5 has been 
isolated from rodents in Russia.
All Brucella species may also infect wildlife species. Classical 
Brucella species have been isolated from a great variety of 
wildlife species such as bison, elk, feral swine, wild boar, fox, 
hare, African buffalo, reindeer, and caribou (10). In order to 
implement appropriate control measures to address wild-
life brucellosis, it is very important to distinguish between 
a spill-over of infection contracted from domestic animals 
and a sustainable infection (10). In the latter case, the con-
cern of the livestock industry is to prevent the re-introduc-
tion of the infection in livestock (spill-back), particularly in 
regions or states that are “officially brucellosis-free.” If the 
status of “officially brucellosis-free” is lost, domestic animals 
must be tested prior to being traded, which imposes huge 
costs. This is exemplified by recent episodes of cattle being 
infected with B. abortus transmitted by elk in the Greater 
Yellowstone Area in the USA (11) and of outdoor reared 
pigs infected with B. suis biovar 2 transmitted by wild boar 
in France (12).
Brucellosis is an established zoonosis: infections have been 
attributed to at least 5 of the 6 classical Brucella species in 
terrestrial mammals. Studies from around the world indi-
cate that elimination of the animal brucellosis reservoir has 
resulted in a substantial decline in the incidence of human 
disease (13). Currently, laboratory workers are among those 
most frequently infected (14). Marine mammal strains of 
Brucella have been reported to cause the infection of a lab-
oratory worker in the UK (15), as well as naturally-acquired 
infections in Peru (16) and New Zealand (17).
Brucella species and biovars, preferential hosts, and patho-
genicity for humans are depicted in Table 1.
The most important clinical sign of brucellosis is abortion 
at the first gestation. Usually, infected females will abort 
only once, although they may remain infected their entire 
life. The clinical diagnosis of brucellosis in animals on the 
basis of abortion is, however, equivocal since many patho-
gens can induce abortion. Laboratory testing is therefore 
essential. The aim of this article is to review the recent lit-
erature on laboratory testing techniques designed to diag-
nose brucellosis.
Overview Of diaGNOStiC methOdS
This section reviews the different methods used to diag-
nose brucellosis in livestock and wildlife. Diagnostic tests 
can be applied with different goals: confirmatory diagno-
sis, screening or prevalence studies, certification, and, in 
countries where brucellosis is eradicated, surveillance in 
order to avoid the reintroduction of brucellosis through 
importation of infected animals or animal products. The 
validation of such diagnostic tests is still an issue, par-
ticularly in wildlife.
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Diagnostic methods include direct tests, involving micro-
biological analysis or DNA detection by polymerase chain 
reaction (PCR)-based methods and indirect tests, which are 
applied either in vitro (mainly to milk or blood) or in vivo 
(allergic test). The choice of a particular testing strategy de-
pends on the prevailing epidemiological situation of bru-
cellosis in susceptible animals (livestock and wildlife) in a 
country or a region. Isolation of Brucella spp. or detection 
of Brucella spp. DNA by PCR is the only method that allows 
certainty of diagnosis. Biotyping provides valuable epide-
miological information that allows tracing of infections 
back to their sources in countries where several biotypes 
are co-circulating. However, when one particular biovar is 
overwhelmingly predominant, classical typing techniques 
are of no use because they do not allow the differentia-
tion of isolates belonging to the same biovar of a given 
species. In this context, new fingerprinting methods such 
as multiple locus variable (number of tandem repeats) 
analysis (MLVA), which measures the number of tandem 
repeats at a given locus and multi-locus sequence analy-
sis (MLSA) can differentiate isolates within a given biovar. 
These methods are gaining wider acceptance and will in 
the coming years almost certainly be used as routine typ-
ing and fingerprinting methods for molecular epidemio-
logical purposes (19-21).
direct diagnosis
Staining. Stamp staining is still often used, even though 
this technique is not specific: other abortive agents such 
as Chlamydophila abortus (formerly Chlamydia psittaci) 
or Coxiella burnetii are also stained red. It provides 
valuable information for the analysis of aborted material 
(1). Brucella spp. is a coccobacillus measuring 0.6-1.5 µm 
long and 0.5-0.7 µm wide. They generally occur singly and 
are observed in clusters of two or more. Brucella spp. is a 
Gram-negative bacterium that can resist weak acidic treat-
ment and therefore appears red after Stamp staining.
Culture. Bacterial isolation is always required for the biotyp-
ing of strains (see “Molecular methods,” below). For the de-
finitive diagnosis of brucellosis, the choice of samples de-
pends on the clinical signs observed. In the case of clinical 
brucellosis, valid samples include aborted fetuses (stom-
ach, spleen, and lung), fetal membranes, vaginal secretions, 
colostrum, milk, sperm, and fluid collected from arthritis or 
hygroma. At slaughter, in order to confirm suspected cases 
of acute or chronic brucellosis, the preferred tissues are the 
genital and oropharyngeal lymph nodes, the spleen, and 
the mammary gland and associated lymph nodes. For the 
isolation of Brucella spp., the most commonly used medi-
um is the Farrell medium, which contains antibiotics able 
to inhibit the growth of other bacteria present in clinical 
samples. Some Brucella species, like B. abortus wildtype (bi-
ovars 1-4), need CO2 for growth, while others, like B. abor-
tus wildtype (biovars 5, 6, 9), B. abortus S19 vaccine strain, B. 
melitensis, and B. suis, do not (1). For liquid samples (milk or 
blood), sensitivity is increased by the use of a biphasic me-
dium like the Castaneda medium, originally described for 
use with human blood cultures. Growth may appear after 
2-3 days, but cultures are usually considered negative after 
2-3 weeks of incubation (1). The identification of Brucella 
spp. is based on morphology, staining and metabolic pro-
file (catalase, oxidase, and urease) (1,2).
table 1. Brucella species and biovars, preferential hosts and pathogenicity for humans
Species biovars Colony morphology Preferential host(s) Pathogenicity in humans*
B. melitensis 1-3 smooth sheep, goat high
B. abortus 1-6, 9 smooth cattle high
B. suis 1, 3 smooth pig high
2 smooth wild boar, hare low
4 smooth reindeer, caribou high
5 smooth rodent no
B. neotomae - smooth desert rat moderate
B. ovis - rough ram no
B. canis - rough dog moderate
B. pinnipedialis - smooth seal ?†
B. ceti - smooth cetacean ?
B. microti - smooth soil, vole, fox ?
B. inopinata - smooth human ?
*Pathogenicity in humans: adapted from the references 1,5,6,9,13,15-18.
†although some human cases have been described, the actual pathogenicity remains unknown.
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Biotyping. Biotyping of Brucella spp. is performed using dif-
ferent tests, the most important being agglutination tests 
with antibodies against rough or smooth LPS, ie, against 
the A or M epitopes of ‘O’ chain polysaccharides (O-LPS); 
lysis by phages, dependence on CO2 for growth, measured 
usually in primary cultures; production of H2S; growth in 
the presence of basal fuchsine or thionine; and the crystal 
violet or acriflavine tests (1). In order to be carried out pro-
ficiently, these techniques must be carried out using stan-
dardized procedures by experienced personnel. Therefore, 
they are often performed only in reference laboratories.
Molecular methods. New techniques allowing identifica-
tion and sometimes quick typing of Brucella have been 
developed and are in use in certain diagnostic laborato-
ries (19-24).
Identification. Several PCR based methods have been de-
veloped. The best validated methods are based on the de-
tection of specific sequences of Brucella spp., such as the 
16S-23S genes, the IS711 insertion sequence or the bcsp31 
gene encoding a 31-kDa protein (25,26). These techniques 
were originally developed on bacterial isolates and are now 
also used to detect Brucella spp. DNA in clinical samples. 
DNA extraction methods known to influence the sensitivity 
of PCR assays need to be evaluated (27). It is worth noting 
that most of these techniques have been validated on hu-
man samples, but some reports evaluate their application 
to clinical veterinary samples (28,29). Recently, one tech-
nique has been favorably evaluated for the diagnosis of B. 
suis biovar 2 in clinical samples originating from wild boar in 
Switzerland (30). It is difficult to provide sensitivity and spec-
ificity estimates for these techniques because the test pro-
tocols described in the respective articles are not the same. 
Nevertheless, as a general rule, brucellosis PCR techniques 
show a lower diagnostic sensitivity than culture methods, 
although their specificity is close to 100% (23,28,29). The 
best results have so far been obtained by combining cul-
ture and PCR detection on clinical samples (28-30).
Molecular typing. For typing of Brucella spp., the multiplex 
AMOS PCR, named for its applicability to “abortus, meliten-
sis, ovis, suis” species, is often used. This PCR and PCR pro-
tocols derived from it allow discrimination between Bru-
cella species and between vaccine and wild-type strains. 
They do not, however, allow discrimination among all the 
biovars of a given Brucella species (22-24). The multiplex 
“Bruce ladder” PCR is the first method designed to iden-
tify and differentiate all of the known Brucella species 
and the vaccine strains in the same test (31).
The lack of PCR-based methods to discriminate among bi-
ovars within a species stimulated the development of oth-
er molecular typing techniques for Brucella spp., such as 
restriction fragment length polymorphism analysis based 
on the number of IS711 insertion sequences. However, this 
has not proven to be a useful tool (32). PCR restriction frag-
ment length polymorphism based on the restriction analy-
sis of Brucella genes encoding outer membrane proteins 
is a simple tool to implement, but the degree of polymor-
phism is low and the robustness is weak (33). Several new 
fingerprinting techniques show promise for differentiating 
isolates within the same biovar of a given species: single-
nucleotide polymorphisms, which detect single-nucleo-
tide differences in the DNA sequence of members of a spe-
cies; MLSA, which detects DNA sequence variations in a set 
of housekeeping genes and characterizes strains by their 
unique allelic profiles; and MLVA, which analyzes the vari-
ability of loci containing repeated sequences (19-21).
To summarize, classical typing methods are able to dis-
criminate between biovars of Brucella but, in a near future, 
single-nucleotide polymorphisms, MLSA, and MLVA will be 
used as routine typing techniques to allow the discrimi-
nation of strains within a given biovar, allowing molecular 
epidemiological analysis.
indirect diagnostic tests
These tests are derived from research done mainly on bru-
cellosis diagnosis in cattle. To a large extent the character-
istics of the different tests can be transposed to sheep and 
goat, except for the milk ring test, which is not an accepted 
test in these species because it generates too many false-
positive results (4).
In pigs, infection by Yersinia enterocolitica serotype O:9 
(YO9) is not uncommon in some areas, particularly in Eu-
rope. Since YO9 and Brucella share a polysaccharide ‘O’ 
chain, Brucella spp. antigens used in serological tests re-
act equally well with the surface smooth LPS of YO9 and 
are therefore unable to distinguish between antibodies to 
these 2 pathogens. Thus, as determined by the World Or-
ganization for Animal Health (Office International des Epi-
zooties, OIE), none of the conventional serological tests 
used for the diagnosis of porcine brucellosis is reliable for 
diagnosis in individual pigs (4).
Several studies of brucellosis serology have been per-
formed in wildlife as well as in zoo collections, with the 
goal of assessing the presence or spread of Brucella 
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spp. within different wild species and to classify species or 
individuals as exposed or non-exposed (4). Brucellosis se-
rology is usually performed using the same antigens as in 
livestock serology because the immunodominant Brucella 
antigens, associated to the smooth LPS, are to a large ex-
tent shared by all naturally occurring biovars of B. abortus, 
B. melitensis, B. suis, B. neotomae, B. ceti, B. pinnipedialis, and 
B. microti. Most brucellosis serological tests have been di-
rectly transposed to wild species, without validation, from 
domestic livestock populations, where their use has quite 
often not been validated either.
In order to validate serological tests, results should be ana-
lyzed according to the true infectious status of an animal. 
The presence of anti-Brucella antibodies suggests expo-
sure to Brucella spp., but it does not indicate which Brucella 
species induced production of those antibodies. Moreover, 
seropositivity does not necessarily mean that the animals 
have current or active infection at the time of sampling. 
In fact, studies of experimental and natural infections in-
dicate that nearly all animal species vulnerable to Brucella 
infection can lose their antibody titers. This means that the 
actual prevalence of brucellosis may be higher than that 
indicated by antibody screening. Therefore, the “gold stan-
dard” in brucellosis remains the isolation of Brucella spp. If 
brucellosis is suspected in livestock or in wildlife because 
of positive serological results, attempts to isolate the or-
ganism are considered mandatory and should always be 
performed (10).
A sound description of the different tests for the diagnosis 
of brucellosis is available online on the OIE Web site (http://
www.oie.int) in the form of the Manual of Diagnostic Tests 
and Vaccines for Terrestrial Animals. In the following section, 
only the primary benefits and shortcomings of the tests will 
be addressed. Sensitivities and specificities of indirect tests, 
as documented in the literature, are depicted in Table 2.
Serological tests. This section refers to serological tests to 
detect “smooth” Brucella spp. infections. These tests do not 
detect infections caused by B. ovis and B. canis. For these in-
fections, “rough” Brucella antigens must be used (4).
Slow Agglutination Test or Slow Agglutination of Wright 
(SAT or SAW). The principle of this test is to detect aggluti-
nin antibodies mainly of the IgM isotype directed against 
Brucella spp. At an optimum concentration of antigen and 
antibodies, large antigen-antibody complexes form and 
precipitate at the bottom of the test tube. This reaction 
is slow because, in contrast to the rapid agglutina-
tion tests, it requires an overnight incubation at 37°C. This 
technique can also be practiced in micromethod (micro-
agglutination test) in a reaction volume of 100 µL, without 
a change in performance. Reading the result is facilitated 
by the addition of a dye that stains the cells. The relative 
lack of specificity and sensitivity of this test has often been 
presented as a major drawback (Table 2). Nevertheless, 
this is a standardized and extremely robust test that has 
shown good results and has proven efficacious in sever-
al countries now declared officially free of brucellosis (34). 
The specificity of the test is increased by treating the serum 
with a chelating agent such as EDTA, which reduces cross-
reactions due to IgM (1). Although this test is no longer rec-
ommended by the OIE for bovine brucellosis diagnosis (4), 
it is still widely used in human brucellosis diagnosis (1).
Buffered Brucella antigen tests. The Rose Bengal (RB) and 
buffered plate agglutination (BA) tests are the well-known 
buffered Brucella antigen tests. These tests are rapid agglu-
tination tests lasting 4 minutes done on a glass plate with 
the help of an acidic-buffered antigen (pH 3.65 ± 0.05). 
These tests have been introduced in many countries as 
the standard screening test because it is very simple and 
thought to be more sensitive than the SAT (35). The OIE 
considers these tests “prescribed tests for trade” (4).
Complement fixation test. The Complement Fixation Test 
(CFT) allows the detection of anti-Brucella antibodies that 
table 2. Sensitivity and specificity of indirect tests for the 
diagnosis of cattle brucellosis as published in the literature*
tests Sensitivity (%) Specificity (%)
Serological tests
SAT (SAW)/MAT 81.5 98.9
CFT 90-91.8 99.7-99.9
BAT 87 97.8








Skin test 78-93 99.8
*abbreviations: Sat – Slow agglutination test; Saw – Slow agglutina-
tion of wright; mat – micro agglutination test; Cft – Complement 
fixation test; bat – buffered Brucella antigen test; ieliSa – indirect 
eliSa; celiSa – competitive eliSa; fPa – fluorescence polarization 
assay; mrt – milk ring test. the data in the table come from refer-
ences 4,34-41.
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are able to activate complement. Cattle immunoglobulins 
(Ig) that can activate bovine complement are the IgG and 
the IgM. According to some literature this test is not high-
ly sensitive but shows an excellent specificity (34,36). Be-
cause the test is difficult to standardize, it is progressively 
being replaced by ELISAs (4). This test is a “prescribed test 
for trade” by the OIE (4).
ELISAs. ELISAs are divided into two categories, the indirect 
ELISA (iELISAs) and the competitive ELISA (cELISAs). Most 
iELISAs use purified smooth LPS as antigen but a good deal 
of variation exists in the anti-bovine Ig conjugate used (37). 
Most iELISAs detect mainly IgGs or IgG sub-classes. Their 
main quality is their high sensitivity but they are also more 
vulnerable to non-specific reactions, notably those due to 
YO9 infection. These cross-reactions seen in iELISAs mo-
tivated the development of cELISAs. The O-chain of the 
smooth LPS of Brucella contains specific epitopes that are 
not shared with the LPS of YO9. Therefore, by using mono-
clonal antibodies directed against specific epitopes of the 
Brucella LPS, the development of more specific cELISAs has 
been possible. These tests are more specific, but less sensi-
tive, than iELISAs (38,42). The OIE considers these tests “pre-
scribed tests for trade” (4).
Fluorescence Polarization Assay. The fluorescence po-
larization assay (FPA) is based on a physical principle: 
how quickly a molecule spins in a liquid medium cor-
relates with its mass. Molecules of small size spin faster 
and depolarize a polarized light beam more, while big-
ger molecules spin more slowly and, consequently, de-
polarize light less. FPA measures the degree of depolar-
ization in milli-polarization units (mP). During the test, 
serum samples are incubated with a specific antigen of 
B. abortus labeled with fluorescein isothiocyanate. In the 
presence of antibodies against Brucella spp., large fluo-
rescent complexes are formed. In negative samples, the 
antigen remains uncomplexed. These smaller molecules 
spin more quickly and therefore cause greater depolari-
sation of the light than do the samples positive for Bru-
cella spp.
This test can be easily automated and is very quick, since af-
ter mixing the labeled antigen and serum the reading is al-
most instantaneous. The test sensitivity seems slightly low-
er than that of iELISAs (36). The specificity varies between 
98.8 and 99.0% (35). This test is already used in brucellosis 
control and certification programs in North America and 
in Europe. The OIE considers this test a “prescribed test for 
trade” (4).
Milk tests. These tests are prescribed by the OIE as tests to 
use in control and eradication programs but not for trad-
ing purposes (4).
Milk Ring Test. The test consists of mixing colored Brucella 
whole-cell antigen with fresh bulk/tank milk. In the pres-
ence of anti-Brucella antibodies, antigen-antibody com-
plexes form and migrate to the cream layer, forming a 
purple ring on the surface. In the absence of antigen-an-
tibody complexes, the cream remains colorless. This test is 
not considered sensitive but this lack of sensitivity is com-
pensated by the fact that the test can be repeated, usually 
monthly, due to its very low cost. This test is prescribed by 
the OIE for use only with cow milk (4).
ELISAs and Fluorescence Polarization Assay. These two 
tests, discussed above in the context of serum samples, 
can also be applied to milk samples to detect infected ani-
mals. These tests are less sensitive when applied to milk 
than to serum samples. Indeed, before they can be used 
on tank milk, which may come from hundreds of cows, 
their sensitivity must first be checked on pools of samples 
(39,40). This lower sensitivity in the case of tank milk can of-
ten be compensated by increasing the testing frequency. 
These tests are prescribed by the OIE for testing the milk of 
cattle and small ruminants (4).
Skin test. The skin test is an allergic test that detects the 
specific cellular immune response induced by Brucella spp. 
infection. The injection of brucellergene, a protein extract 
of a rough strain of Brucella spp., is followed by a local in-
flammatory response in a sensitized animal. This delayed-
type hypersensitivity reaction is measured by the increase 
in skin thickness at the site of inoculation. This test is high-
ly efficient in discriminating between true brucellosis cas-
es and false positive serological reactions. The skin test is 
highly specific but its weak sensitivity makes it a good test 
for herds but not for individual certification. It cannot dis-
criminate between infection and vaccination (41). This test 
is prescribed as an alternative test by the OIE (4).
StrateGiC uSe Of SerOlOGiCal teStS
This section highlights the strategic use of certain serologi-
cal tests in order to discriminate 1) between false positive 
serological reactions and true brucellosis and 2) between 
vaccination and infection.
Brucellosis is an infectious disease but animals are not 
always contagious. Indeed, excretion of Brucella spp. 
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only occurs at certain times, mainly when abortion occurs. 
During an abortion, billions of Brucella spp. are excreted 
and this is a major source of infection for congeners and 
for professionals in contact with aborted materials. In order 
to avoid contamination from aborted material, it is impor-
tant (1) to isolate pregnant heifers in their sixth month of 
pregnancy, given that brucellosis induces abortion usually 
in late pregnancy; and 2) to predict abortion and eliminate 
animals likely to abort, before they become a source of 
infection. Vaccination does not provide complete protec-
tion from exposure to Brucella spp. (4). This raises the key 
question: when a pregnant animal is infected, regardless of 
whether or not it has been vaccinated, is it possible to pre-
dict whether it will abort? Key factors that determine the 
answer to this question are the kinetics of antibody pro-
duction and the type of antibodies produced.
Kinetics of the immune responses in cattle
Indirect diagnostic tests are based on the detection of im-
mune responses induced by infection. These tests show 
different sensitivities and specificities depending on nu-
merous variables, such as the infection dose and route, the 
presence of so-called “cross-reactive bacteria” antigenical-
ly similar to Brucella spp., the kinetics of the induced im-
mune response, and previous vaccination (37,43). Se-
rology is the method of choice for screening in any 
sound control or eradication program. Strong humoral im-
mune responses are induced after exposure. Humoral IgG 
responses persist after the peak of the response (3-4 weeks 
post-infection) and remain detectable over long periods 
of time (up to several years); in contrast, the IgM response 
is rapidly induced 2-3 weeks after exposure and may dis-
appear after a few months (37,43,44). The cell-mediated 
immune response (induced 3-4 weeks after exposure), as 
measured by the brucellosis skin test, is long-lasting and 
can be detected for several years (41). Thus, given the ki-
netics of the immune responses induced after infection, 
the time when different tests are performed after exposure 
has a major impact on the results, as depicted in Figure 1.
The kinetics of production and disappearance of the prin-
cipal immunoglobulin isotypes during infection, and the 
activity of these immunoglobulins in the different serologi-
cal tests, will usually permit the distinction between acute 
and chronic infections. For example, the immune respons-
es against B. abortus in cattle are rapid IgM production 2-3 
weeks after experimental infection, followed by IgG pro-
duction 3-4 weeks after experimental infection (41,43,44). 
Therefore, the following principles apply:
1. The concomitant presence of IgM (detected in an agglu-
tination test) and IgG (detected in iELISA) suggests acute 
brucellosis, while chronic brucellosis is characterized by 
the presence of IgG alone.
2. A positive response in an agglutination test, which de-
tects mainly IgM, is not indicative of brucellosis if it is not 
confirmed by a positive IgG response by iELISA within one 
week.
The SAT, RB, and BAT are commonly used as screening tests 
for the diagnosis of bovine brucellosis. However, the OIE 
and the EU have recently decided not to recommend use 
of the SAT because they consider it inferior to the other 
standard tests (4,35). The CFT is used as a confirmatory test 
after a positive agglutination reaction. This test is gradu-
ally being replaced by iELISAs and, more recently, by the 
FPA (4). All these tests must be standardized and should be 
performed according to validated standard operating pro-
cedures in accredited laboratories.
Serology and vaccination
For over 60 years, the B. abortus S19 vaccine has been 
used in cattle and the B. melitensis Rev.1 vaccine has been 
used in sheep and goats to prevent abortion and infertil-
Figure 1.
Outcome of Slow agglutination test (Sat) and eliSa tests performed at different times post-in-
fection. according to the time point post-infection at which sampling and testing occur, differ-
ent serological results may be generated. therefore, epidemiological informations are extremely 
important for informing the interpretation of test results. immunoglobulin (igG) responses will 
be induced 1 or 2 weeks later than the igm response but they will last for long periods of time, 
usually years. the intensity of the response is measured by serum antibody titers using slow ag-
glutination test, which measures mainly igm, and indirect eliSa (ieliSa), which measures mainly 
igG. testing was performed 3 weeks, 4 weeks, 6-7 months, and more than a year post-infection. 
adapted from references 41,43,44.
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ity caused by natural infection with virulent strains of these 
Brucella species (45). These vaccines, combined with sero-
logic surveillance tests, have been instrumental in the suc-
cess of the brucellosis eradication program. Conventional 
serologic tests for brucellosis detect antibody against the 
LPS antigens induced by vaccination with S19 or Rev. 1 or 
exposure to virulent field strains. Therefore, no single sero-
logic test can differentiate, beyond any reasonable doubt, 
animals vaccinated with S19 or Rev. 1 and animals infected 
with virulent Brucella spp. field strains. Nevertheless, stra-
tegic use of tests to detect different isotypes of immuno-
globulins provides useful information in order to differen-
tiate vaccination from infection. Indeed, more than 90% 
of heifers vaccinated with S19 were classified negative by 
classical serological tests (ie, SAT, RB, and CFT) at 16 weeks 
post-vaccination, while they were still classified positive by 
iELISAs (41). Moreover, under experimental conditions, the 
kinetics of antibody production differ between vaccina-
tion and infection such that iELISAs can be used to predict 
abortion in heifers and thus allow their elimination before 
congeners can be contaminated (41).
Recently, a rough mutant of B. abortus, strain RB51, has 
been proposed for use as a vaccine for cattle of all ages (46). 
Although RB51 expresses low levels of the O side chain, na-
ive animals remain seronegative in surveillance tests fol-
lowing vaccination with RB51 (47). This is a major advan-
tage in a control program based on vaccination combined 
with serological testing. Unfortunately, the efficacy of the 
RB51 vaccine in cattle is still questionable (45). RB51 has 
been shown to be non-protective in small ruminants (48). 
Currently, there is no vaccine available for humans, pigs, or 
wildlife (10,18).
CONCluSiON
The aim of an eradication program is not a “zero seropos-
itivity” situation, but the absence of infection, given that 
seropositivity can occur after vaccination or YO9 infection 
(44). Criteria to declare a country or a region “officially free 
from brucellosis” have been laid down in international reg-
ulations such as in EU Directives and recommendations of 
the OIE. The epidemiology of brucellosis is complex and 
criteria other than test results are needed in order to guar-
antee the success of an eradication program (49). The S19 
and Rev. 1 vaccines are still the cornerstones of control and 
eradication programs (4).
In contrast, no vaccine is available against brucellosis in 
wildlife. It is striking to see that the ecology of infection re-
mains so poorly understood. For example, scientists have 
speculated for decades whether brucellosis induces abor-
tion in bison (50). Little is known about the pathology of B. 
suis biovar 2 in wild boars (51), and marine mammal bru-
cellosis research is still in its infancy (18). Very little is known 
about brucellosis pathology in marine mammals (52) or 
their zoonotic potential (53). Emphasis should be put on 
multidisciplinary research addressing the ecology of infec-
tion, particularly on how to predict whether infection will 
persist in a population. Research should also analyze the 
factors of crucial importance for the maintenance of Bru-
cella spp. in infected populations. Serology is the first tool 
in detecting subclinical infections. Better tests and testing 
strategies should be developed but the “gold standard” in 
brucellosis remains the isolation of Brucella spp. and is thus 
mandatory.
Brucellosis is not a sustainable disease in humans. The 
source of human infection resides always in domestic or 
wild animal reservoirs. Therefore, as a general rule, preven-
tion of human zoonotic brucellosis depends predominant-
ly on the control of the disease in animals (13,18).
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